Imagine you are reviewing the five-year financial model for a mid-cap Indian manufacturing firm. You notice that the company’s Return on Equity (ROE) has surged from 15% to 22% over the last three years, and your initial...
You are sitting in a meeting with your firm’s investment committee, presenting a valuation model for a leading Indian FMCG company. Your spreadsheet shows a robust, linear growth in operating margins based on a five-year...
You are sitting at your desk late on a Tuesday, finalizing a research note on a mid-cap manufacturing firm based in Pune. Your spreadsheet model predicts a healthy 18% return on equity based on historical averages, and...
You are sitting at your desk on a Tuesday morning, analyzing a mid-cap manufacturing firm that appears to trade at a P/E of 12x, while its primary competitors are trading at 18x. Your initial instinct might be to issue a...
You are deep into building a DCF model for a mid-cap manufacturing firm that has just announced a rights issue to fund a new capacity expansion. Your initial valuation suggests a healthy upside, but you pause when...
You are deep into your quarterly analysis of a mid-cap IT firm that has historically reinvested every rupee of profit into R&D and expansion. Suddenly, the company announces a maiden dividend payout, breaking years of...
You are deep into your quarterly review of a high-growth IT services firm, comparing its 25% Return on Equity (ROE) against its main competitor. While the headline number looks impressive, a simple ROE calculation fails...
As a research analyst, you are reviewing the quarterly filing of a mid-cap manufacturing firm that has just announced an open-market share buyback. Your initial observation is that the management claims this action is a...
Imagine you are reviewing the annual report of a high-growth tech firm listed on the NSE. The Basic EPS shows a healthy double-digit growth, and your valuation model suggests an attractive entry price. However, when you...
You are reviewing a mid-cap firm's latest board announcement proposing a preferential allotment to a group of sophisticated investors. At first glance, the capital injection seems like a boost to the balance sheet, but...